Are Pretreatment Inflammation-Based Prognostic Scores Useful in Predicting the Outcomes of Patients with ALK-Positive NSCLC?
dc.contributor.author | Olmez, O. F. | |
dc.contributor.author | Bilici, A. | |
dc.contributor.author | Gursoy, P. | |
dc.contributor.author | Cubukcu, E. | |
dc.contributor.author | Yildiz, O. | |
dc.contributor.author | Sakin, A. | |
dc.contributor.author | Hamdard, J. | |
dc.date.accessioned | 2020-12-01T12:09:11Z | |
dc.date.available | 2020-12-01T12:09:11Z | |
dc.date.issued | 2019 | |
dc.department | Ege Üniversitesi | en_US |
dc.description | DEMIR, TARIK/0000-0001-6334-4079 | en_US |
dc.description.abstract | [No abstract available] | en_US |
dc.identifier.doi | 10.1016/j.jtho.2019.08.1152 | |
dc.identifier.endpage | S552 | en_US |
dc.identifier.issn | 1556-0864 | |
dc.identifier.issn | 1556-1380 | |
dc.identifier.issue | 10 | en_US |
dc.identifier.startpage | S551 | en_US |
dc.identifier.uri | https://doi.org/10.1016/j.jtho.2019.08.1152 | |
dc.identifier.uri | https://hdl.handle.net/11454/63352 | |
dc.identifier.volume | 14 | en_US |
dc.identifier.wos | WOS:000492162203068 | en_US |
dc.identifier.wosquality | Q1 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.language.iso | en | en_US |
dc.publisher | Elsevier Science Inc | en_US |
dc.relation.ispartof | Journal of Thoracic Oncology | en_US |
dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | Inflammation-based prognostic scores | en_US |
dc.subject | Non small cell lung cancer | en_US |
dc.subject | Anaplastic lymphoma kinase | en_US |
dc.title | Are Pretreatment Inflammation-Based Prognostic Scores Useful in Predicting the Outcomes of Patients with ALK-Positive NSCLC? | en_US |
dc.type | Conference Object | en_US |